Abstract
Recent developments in (molecular) genetics have led to a better understanding of renal tumor biology. The current knowledge of the genetics of benign as well as malignant renal tumors is discussed briefly. This knowledge may, in the near future, be used to more accurately diagnose these tumors and also to optimalize individually based therapy.
References
Clark J, Lu YJ, Sidhar SK, Parker C, Gill S, Smedley D, Hamoudi R, Linehan WM, Shipley J, Cooper CS (1997) Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15: 2233
Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER (1998) Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chrom Cancer 22: 200
Fischer J, Palmedo G, von Knobloch R, Bugert P, Prayer-Galetti T, Pagano F, Kovacs G (1998) Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumors. Oncogene 17: 733
Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky IA, Duan R, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks,JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM (1994) Mutation of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7: 85
Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei M, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan S-RD, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AL, Maher ER, Lineham WM, Zbar B, Lerman MI (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317
Mickisch GH, Carballido J, Hellsten S, Schulze H, Mensink H (2001) Guidelines on renal cell cancer. Eur Urol 40: 252
Philips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt WM, Linehan WM, Klausner RD, Ried T (2001) Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Genes Chrom Cancer 31: 1
Philips JL, Pavlovich CP, Walther M, Ried T, Linehan WM (2001) The genetic basis of renal epithelial tumors: advances in research and its impact on prognosis and therapy. Curr Opin Urol 11: 463
Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky IA, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis TJ, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJM, Walther MM, Tsui L, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B, (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papaillary renal cell carcinomas. Nat Genet 16: 68
Schmidt L, Junker K, Weirich G, Glenn G, Choyke P, Lubensky 1A, Zhuang Z, Jeffers M, Woude GV, Neumann H, Walther,MM, Linehan WM, Zbar B(1998) Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res 58: 1719
Schmidt LS, Warren MB, Nickerson ML, Weirich G, Matrosova V, Toro JR, Turner ML, Duray P, Merino M, Hewitt S, Pavlovich CP, Glenn G, Greenberg CR, Linehan WM, Zbar B (2001) Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17pl 1.2. Am J Hum Genet 69: 876
Shipley JM, Birdsall S, Clark J, Crew J, Gill S, Linehan WM, Gnarra JR, Fisher S, Craig IW, Cooper CS (1995) mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X; 1)(p11.2;q21.2) and the first report of a female case. Cytogenet Cell Genet 71: 280
Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary renal cell carcinomas. Cancer Res 54: 2852
Sidhar SK, Clark J, Gill S, Hamoudi R, Crew J, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J, Cooper CS (1996) The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 5: 1333
Storkel S, Eble IN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Icskowski K (1997) Classification of renal cell carcinoma: workgroup no. 1. Cancer 80: 987
Weterman MA, van Groningen JJ, den Hartog A, Geurts van Kessel A (2001) Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes. Oncogene 22: 1414
Zambrano NR, Lubensky IA, Merino MJ, Linehan WM, Walther MM (1999) Histopathology and molecular genetics of renal tumors: toward unification of a classification system. J Urol 162: 1246
Zbar B, Tory K, Merino M, Schmidt L, Glenn G, Choyke P, Walther MM, Lerman M, Linehan WM (1994) Hereditary papillary renal cell carcinoma. J Urol 151: 561